Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations.

Authors:
Ramani G; Cassady S; Shen E; Broderick M; Wasik A and 2 more

Journal:
Pulm Circ

Publication Year: 2020

DOI:
10.1177/2045894020923956

PMCID:
PMC8826281

PMID:
35154662

Journal Information

Full Title: Pulm Circ

Abbreviation: Pulm Circ

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The University of Maryland contracts with United Therapeutics Corporation and Actelion Pharmaceuticals Ltd. for GR to perform research. SC and AW do not have any conflicts of interest to declare and does not have affiliations with institutions, organizations, or companies mentioned in the manuscript or whose products or services are discussed. ES, MB, QS, and AN are employees or contractors of United Therapeutics Corporation."

Evidence found in paper:

"Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025